AtriCure, Inc. (Nasdaq:ATRC), a medical device company and a leader in the development of technologies and solutions for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, will release its financial results for the first quarter of 2013 on Thursday, May 2, 2013.
